<DOC>
	<DOCNO>NCT00297817</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity two serogroup B meningococcal vaccine comparison placebo administer healthy adolescent age 11 18 year .</brief_summary>
	<brief_title>Study Safety Immune Response Two Serogroup B Meningococcal Vaccines Administered Healthy Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Adolescents include 1118 year age , provide write informed consent . Previous suspected disease cause N. meningitidis ; previous immunization serogroup B meningococcal vaccine ; Any acute , chronic progressive disease .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Meningococcal Disease ; Meningococcal Meningitis ; Vaccine</keyword>
</DOC>